Sunitinib in combination with capecitabine within its licensed indication for the treatment of advanced and/or metastatic breast cancer
| Status: |
In progress |
| Expected date of issue: |
October 2011 |
| Referral date: |
March 2009 |
| Wave: |
19 |
| Process: |
STA |
| Notes:
Cancer reform strategy Batch 5
|
| Topic area:
|
NICE project team
| Executive Lead: |
Gillian Leng
|
| Technical Lead: |
Ruaraidh hill
|
| Communications manager: |
Laura Gibson
|
| Project manager: |
Laura Malone
|
|
Evidence review group:
|
Peninsula Technology Assessment Group (PenTAG) |
Provisional schedule
| Closing date for invited submissions / evidence submission: |
3 February 2011 |
| 1st appraisal committee meeting: |
11 May 2011 |
| 2nd appraisal committee meeting |
TBC |
Consultees and Commentators
Project history
| Date |
Update |
| 23 September 2009 |
Please note that following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid November 2010. The deadline for submissions is expected in approximately early February 2011. |
|
Key documents
|
|
|
This page was last updated: 14 January 2010 |
